niacinamide has been researched along with Adrenal Cancer in 8 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sorafenib is a multikinase inhibitor that is used for the treatment of metastatic renal-cell carcinoma." | 5.37 | Painless acute pancreatitis associated with sorafenib treatment: a case report. ( Fujimoto, T; Itatani, H; Kamoto, A; Kanemitu, T; Kobayashi, Y; Mori, N; Satoh, M; Sekii, K; Yoshioka, T, 2011) |
| "Sorafenib is a multikinase inhibitor that is used for the treatment of metastatic renal-cell carcinoma." | 1.37 | Painless acute pancreatitis associated with sorafenib treatment: a case report. ( Fujimoto, T; Itatani, H; Kamoto, A; Kanemitu, T; Kobayashi, Y; Mori, N; Satoh, M; Sekii, K; Yoshioka, T, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, W | 1 |
| Zeng, ZC | 1 |
| Haraldsdottir, S | 1 |
| Li, Q | 1 |
| Villalona-Calero, MA | 1 |
| Olencki, TE | 1 |
| Kendra, K | 1 |
| Ing, SW | 1 |
| Denorme, M | 1 |
| Yon, L | 1 |
| Roux, C | 1 |
| Gonzalez, BJ | 1 |
| Baudin, E | 1 |
| Anouar, Y | 1 |
| Dubessy, C | 1 |
| Maksimovic, O | 1 |
| Schraml, C | 1 |
| Hartmann, JT | 1 |
| Bitzer, M | 1 |
| Claussen, CD | 1 |
| Pintoffl, J | 1 |
| Horger, M | 1 |
| Kobayashi, Y | 1 |
| Kanemitu, T | 1 |
| Kamoto, A | 1 |
| Satoh, M | 1 |
| Mori, N | 1 |
| Sekii, K | 1 |
| Yoshioka, T | 1 |
| Itatani, H | 1 |
| Fujimoto, T | 1 |
| Fabries, P | 1 |
| Pauleau, G | 1 |
| Brardjanian, S | 1 |
| Artéaga, C | 1 |
| Guisset, M | 1 |
| Coton, T | 1 |
| Davis, LH | 1 |
| Kauffman, FC | 1 |
| Gardner, DA | 1 |
| Sato, GH | 1 |
| Kaplan, NO | 1 |
8 other studies available for niacinamide and Adrenal Cancer
| Article | Year |
|---|---|
Is it time to adopt external beam radiotherapy in the NCCN guidelines as a therapeutic strategy for intermediate/advanced hepatocellular carcinoma?.
Topics: Adrenal Gland Neoplasms; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Hepatocellular; Chemoembo | 2013 |
Case of sorafenib-induced thyroid storm.
Topics: Adrenal Gland Neoplasms; Aged; Amiodarone; Anti-Arrhythmia Agents; Antineoplastic Agents; Atrial Fib | 2013 |
Both sunitinib and sorafenib are effective treatments for pheochromocytoma in a xenograft model.
Topics: Administration, Oral; Adrenal Gland Neoplasms; Angiogenesis Inhibitors; Animals; Apoptosis; Cell Sur | 2014 |
Evaluation of response in malignant tumors treated with the multitargeted tyrosine kinase inhibitor sorafenib: a multitechnique imaging assessment.
Topics: Adrenal Gland Neoplasms; Aged; Benzenesulfonates; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; | 2010 |
Painless acute pancreatitis associated with sorafenib treatment: a case report.
Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Huma | 2011 |
[Metastatic adrenal necrosis under sorafenib treatment for hepatocellular carcinoma].
Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; Antineoplastic Agents; Carcinoma, H | 2013 |
Metabolism via the pentose phosphate pathway in rat pheochromocytoma PC12 cells: effects of nerve growth factor and 6-aminonicotinamide.
Topics: 6-Aminonicotinamide; Adrenal Gland Neoplasms; Animals; Carbon Dioxide; Cell Line; Gluconates; Glucos | 1987 |
Pyridine nucleotides in normal and nicotinamide depleted adrenal tumor cell cultures.
Topics: Acetates; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Animals; Azaserine; Cell Line; Cell | 1972 |